Michael Aviram

Active 1972–2022

104
Papers
20,140
Citations
88
h-index
104
i10-index

Citations

Citations per year for Michael Aviram1964: 1 citations1973: 1 citations1974: 3 citations1975: 3 citations1976: 3 citations1977: 3 citations1978: 2 citations1979: 2 citations1980: 1 citations1981: 3 citations1983: 2 citations1984: 2 citations1985: 1 citations1986: 1 citations1987: 2 citations1988: 2 citations1989: 3 citations1990: 1 citations1991: 3 citations1992: 9 citations1993: 11 citations1994: 21 citations1995: 21 citations1996: 32 citations1997: 43 citations1998: 96 citations1999: 97 citations2000: 160 citations2001: 132 citations2002: 233 citations2003: 241 citations2004: 267 citations2005: 344 citations2006: 245 citations2007: 208 citations2008: 252 citations2009: 242 citations2010: 247 citations2011: 205 citations2012: 190 citations2013: 188 citations2014: 159 citations2015: 156 citations2016: 85 citations2017: 126 citations2018: 90 citations2019: 407 citations2020: 326 citations2021: 337 citations2022: 267 citations2023: 193 citations2024: 266 citations2025: 80 citations1965–1972: no citations, so these years are not shown1982: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,039 citing papers, 19.6% of this breakdownChina: 433 citing papers, 8.2% of this breakdownItaly: 368 citing papers, 6.9% of this breakdownUnited Kingdom: 232 citing papers, 4.4% of this breakdownSpain: 225 citing papers, 4.2% of this breakdownIsrael: 207 citing papers, 3.9% of this breakdownGermany: 189 citing papers, 3.6% of this breakdownIndia: 189 citing papers, 3.6% of this breakdownIran: 153 citing papers, 2.9% of this breakdownJapan: 150 citing papers, 2.8% of this breakdownAustralia: 145 citing papers, 2.7% of this breakdownFrance: 145 citing papers, 2.7% of this breakdown
0%19.6%Other 34.5%

Fields

  • Medicine45.9%
  • Biochemistry, Genetics and Molecular Biology20.3%
  • Nursing15.5%
  • Pharmacology, Toxicology and Pharmaceutics5.6%
  • Agricultural and Biological Sciences4.6%
  • Immunology and Microbiology3.7%
  • Other4.4%

Topics

  • Phytochemicals and Antioxidant Activities7.9%
  • Antioxidant Activity and Oxidative Stress6.4%
  • Pomegranate: compositions and health benefits5.5%
  • Paraoxonase enzyme and polymorphisms3.7%
  • Atherosclerosis and Cardiovascular Diseases2.3%
  • Lipoproteins and Cardiovascular Health2%
  • Other72.2%

Coauthors

All papers

Open in search
  1. Glycine-based treatment ameliorates NAFLD by modulating fatty acid oxidation, glutathione synthesis, and the gut microbiome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wanqing Liu, Jifeng Zhang, Y. Eugene Chen - Science Translational Medicine 2020 cited by 279

  2. Comparison of Antioxidant Potency of Commonly Consumed Polyphenol-Rich Beverages in the United States

    Authors: , , , , , , - Journal of Agricultural and Food Chemistry 2008 cited by 686

  3. Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E–deficient mice

    Authors: , , , , , , , , - American Journal of Clinical Nutrition 2000 cited by 861

  4. Polyphenols and Human Health: A Prospectus

    Authors: , , , , , , , , , , , , , - Critical Reviews in Food Science and Nutrition 2011 cited by 339

  5. Induction of glutathione biosynthesis by glycine-based treatment mitigates atherosclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Redox Biology 2022 cited by 52

  6. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation

    Authors: , , , , , , , , , , - Clinical Nutrition 2003 cited by 620

  7. Antioxidant Constituents from Licorice Roots: Isolation, Structure Elucidation and Antioxidative Capacity Toward LDL Oxidation

    Authors: , , - Free Radical Biology and Medicine 1997 cited by 552

  8. Antioxidant Activity, Polyphenol Content, and Related Compounds in Different Fruit Juices and Homogenates Prepared from 29 Different Pomegranate Accessions

    Authors: , , , , , - Journal of Agricultural and Food Chemistry 2007 cited by 390

  9. Anti-oxidative effects of pomegranate juice (PJ) consumption by diabetic patients on serum and on macrophages

    Authors: , , - Atherosclerosis 2005 cited by 317

  10. The antioxidant HDL-associated paraoxonase-1 (PON1) attenuates diabetes development and stimulates β-cell insulin release

    Authors: , , , - Atherosclerosis 2011 cited by 102

  11. Dysregulated oxalate metabolism is a driver and therapeutic target in atherosclerosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cell Reports 2021 cited by 49

  12. Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure

    Authors: , - Atherosclerosis 2001 cited by 432

  13. Pomegranate Phenolics from the Peels, Arils, and Flowers Are Antiatherogenic: Studiesin Vivoin Atherosclerotic Apolipoprotein E-Deficient (E0) Mice andin Vitroin Cultured Macrophages and Lipoproteins

    Authors: , , , , , , - Journal of Agricultural and Food Chemistry 2008 cited by 260

  14. OXIDATIVE STRESS IN ARTERIOGENIC ERECTILE DYSFUNCTION: PROPHYLACTIC ROLE OF ANTIOXIDANTS

    Authors: , , , - The Journal of Urology 2005 cited by 155

  15. Phase II Study of Pomegranate Juice for Men with Rising Prostate-Specific Antigen following Surgery or Radiation for Prostate Cancer

    Authors: , , , , , , , , , , , , , - Clinical Cancer Research 2006 cited by 461

  16. Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase Activities

    Authors: , , , , , , , , , - Arteriosclerosis Thrombosis and Vascular Biology 1998 cited by 454

  17. Hypocholesterolemic Effect of Lycopene and β-Carotene Is Related to Suppression of Cholesterol Synthesis and Augmentation of LDL Receptor Activity in Macrophages

    Authors: , , - Biochemical and Biophysical Research Communications 1997 cited by 320

  18. Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice

    Authors: , , , , , , , , , , , , , , , , - EBioMedicine 2019 cited by 62

  19. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development

    Authors: , - Free Radical Biology and Medicine 2004 cited by 436

  20. Ginger Extract Consumption Reduces Plasma Cholesterol, Inhibits LDL Oxidation and Attenuates Development of Atherosclerosis in Atherosclerotic, Apolipoprotein E-Deficient Mice

    Authors: , , , , - Journal of Nutrition 2000 cited by 325

  21. The Catalytic Histidine Dyad of High Density Lipoprotein-associated Serum Paraoxonase-1 (PON1) Is Essential for PON1-mediated Inhibition of Low Density Lipoprotein Oxidation and Stimulation of Macrophage Cholesterol Efflux

    Authors: , , , , , , - Journal of Biological Chemistry 2006 cited by 242

  22. Grape Powder Polyphenols Attenuate Atherosclerosis Development in Apolipoprotein E Deficient (E0) Mice and Reduce Macrophage Atherogenicity

    Authors: , , , - Journal of Nutrition 2005 cited by 129

  23. Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPARγ and AP-1 pathway activation

    Authors: , , - Atherosclerosis 2007 cited by 112

  24. Effects of Date (Phoenix dactylifera L., Medjool or Hallawi Variety) Consumption by Healthy Subjects on Serum Glucose and Lipid Levels and on Serum Oxidative Status: A Pilot Study

    Authors: , , , , , , - Journal of Agricultural and Food Chemistry 2009 cited by 98